AEON Biopharma (AEON) Treasury Shares (2021 - 2026)

AEON Biopharma (AEON) posted Treasury Shares of $23000.0 for Q4 2022.

AEON Biopharma (AEON) Treasury Shares (2021 - 2026) Analysis & Trends

AEON Biopharma has reported Treasury Shares for 1 years, with the latest figure at $23000.0 in Q4 2022.

Quarterly Treasury Shares fell 17.96% year-over-year to $9351.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9351.0 (down 17.96% YoY) and the FY2025 annual result came in at $14215.0, up 24.71% from the prior year.
Treasury Shares declined to $9351.0 in Q4 2025 per AEON's latest filing, from $14215.0 in the prior quarter.
Over five years, Treasury Shares peaked at $27.6 million in Q1 2021 and troughed at $9351.0 in Q4 2025.
A 5-year average of $11.3 million and a median of $1.2 million in 2023 frame the typical range for Treasury Shares.
The sharpest annual moves came in 2022 and 2023: Treasury Shares changed 0.0% in 2022, then sank 99.93% in 2023.
Over 5 years, Treasury Shares stood at $21.3 million in 2021, then changed by 0.0% to $21.3 million in 2022, then tumbled by 99.93% to $14075.0 in 2023, then retreated by 19.02% to $11398.0 in 2024, then declined by 17.96% to $9351.0 in 2025.
According to Business Quant data, Treasury Shares over the past three periods registered $9351.0, $14215.0, and $14215.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	2.72 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	8.96 Mn
10	AEON Biopharma	10.06 Mn	6.62 Mn	-	-

Download Data